IN2013MU02696A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02696A
IN2013MU02696A IN2696MU2013A IN2013MU02696A IN 2013MU02696 A IN2013MU02696 A IN 2013MU02696A IN 2696MU2013 A IN2696MU2013 A IN 2696MU2013A IN 2013MU02696 A IN2013MU02696 A IN 2013MU02696A
Authority
IN
India
Prior art keywords
sophorolipid
present
emulsion
water
niosomes
Prior art date
Application number
Other languages
English (en)
Inventor
Uday Shriram Annapure
Vinit Kamalkishor Bajaj
Pradeep Ratilal Vavia
Ketankumar Dilipkumar Patel
Original Assignee
Uday Shriram Annapure
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uday Shriram Annapure filed Critical Uday Shriram Annapure
Priority to IN2696MU2013 priority Critical patent/IN2013MU02696A/en
Publication of IN2013MU02696A publication Critical patent/IN2013MU02696A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN2696MU2013 2013-08-19 2013-08-19 IN2013MU02696A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2696MU2013 IN2013MU02696A (enExample) 2013-08-19 2013-08-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2696MU2013 IN2013MU02696A (enExample) 2013-08-19 2013-08-19

Publications (1)

Publication Number Publication Date
IN2013MU02696A true IN2013MU02696A (enExample) 2015-07-03

Family

ID=54396001

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2696MU2013 IN2013MU02696A (enExample) 2013-08-19 2013-08-19

Country Status (1)

Country Link
IN (1) IN2013MU02696A (enExample)

Similar Documents

Publication Publication Date Title
IL269444B (en) New modified indazoles, methods for their production, pharmaceutical preparations containing the new modified indazoles, and the use of the new modified indazoles in the production of drugs
MX2023000320A (es) Metodos para modular los niveles de farmaco en plasma mediante el uso de eritrohidroxibupropion.
MX2015010083A (es) Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos.
SG11201609966SA (en) Drug delivery system and method of use
EA201692213A1 (ru) Мицеллярный нанокомплекс
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
MX2016005395A (es) Formulacion estable de insulina glulisina.
HK1220109A1 (zh) 含卡巴拉汀的经皮给药系统
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
EP3017815A4 (en) Use of naringenin in preparing drugs for preventing and/or treating abdominal aortic aneurysm
MX2015016676A (es) Soluciones orales estables para api combinados.
CR20150444A (es) Composición fertilizante y método para suspender fertilizante en una solución acuosa
EA201992832A1 (ru) Подкожное введение adamts13
EP3162804A8 (en) New benzodiazepine derivative and use thereof
MY174729A (en) Pharmaceutical combination drug
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2016006738A (es) Procedimiento para producir material particulado inorganico.
BR112017019364A2 (pt) dispersões sólidas
IN2013MU02696A (enExample)
MX2016003230A (es) Complejo lubricante para la boca.
FR3014874B1 (fr) Agent epaississant hydrosoluble pour systemes aqueux, formulations le contenant et utilisations
MX2022001772A (es) Formulaciones de isotretinoina y usos y metodos de las mismas.
IN2012DE00826A (enExample)
ZA201509353B (en) Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereof